Literature DB >> 9971787

An important role for major histocompatibility complex class I-restricted T cells, and a limited role for gamma interferon, in protection of mice against lethal herpes simplex virus infection.

A X Holterman1, K Rogers, K Edelmann, D M Koelle, L Corey, C B Wilson.   

Abstract

Herpes simplex virus (HSV) inhibits major histocompatibility complex (MHC) class I expression in infected cells and does so much more efficiently in human cells than in murine cells. Given this difference, if MHC class I-restricted T cells do not play an important role in protection of mice from HSV, an important role for these cells in humans would be unlikely. However, the contribution of MHC class I-restricted T cells to the control of HSV infection in mice remains unclear. Further, the mechanisms by which these cells may act to control infection, particularly in the nervous system, are not well understood, though a role for gamma interferon (IFN-gamma) has been proposed. To address the roles of MHC class I and of IFN-gamma, C57BL/6 mice deficient in MHC class I expression (beta2 microglobulin knockout [beta2KO] mice), in IFN-gamma expression (IFN-gammaKO mice), or in both (IFN-gammaKO/beta2KO mice) were infected with HSV by footpad inoculation. beta2KO mice were markedly compromised in their ability to control infection, as indicated by increased lethality and higher concentrations of virus in the feet and spinal ganglia. In contrast, IFN-gamma appeared to play at most a limited role in viral clearance. The results suggest that MHC class I-restricted T cells play an important role in protection of mice against neuroinvasive HSV infection and do so largely by mechanisms other than the production of IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9971787      PMCID: PMC104449     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

Review 1.  The role of immune mechanisms in control of herpes simplex virus infection of the peripheral nervous system.

Authors:  A Simmons; D Tscharke; P Speck
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

Review 2.  The role of T cell immunity in control of herpes simplex virus.

Authors:  D S Schmid; B T Rouse
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

3.  Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells.

Authors:  B H Koller; P Marrack; J W Kappler; O Smithies
Journal:  Science       Date:  1990-06-08       Impact factor: 47.728

4.  Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system.

Authors:  A A Nash; A Jayasuriya; J Phelan; S P Cobbold; H Waldmann; T Prospero
Journal:  J Gen Virol       Date:  1987-03       Impact factor: 3.891

5.  Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection.

Authors:  M L Cook; J G Stevens
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

6.  Apparent requirement for CD4+ T cells in primary anti-herpes simplex virus cytotoxic T-lymphocyte induction can be overcome by optimal antigen presentation.

Authors:  C M Mercadal; S Martin; B T Rouse
Journal:  Viral Immunol       Date:  1991       Impact factor: 2.257

7.  Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus.

Authors:  E Feduchi; M A Alonso; L Carrasco
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

8.  Role of the virion host shutoff (vhs) of herpes simplex virus type 1 in latency and pathogenesis.

Authors:  L I Strelow; D A Leib
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Restricted replication of herpes simplex virus in spinal ganglia of resistant mice is accompanied by an early infiltration of immunoglobulin G-bearing cells.

Authors:  M L Cook; J G Stevens
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

10.  Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons.

Authors:  A Simmons; D C Tscharke
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

View more
  12 in total

1.  Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing.

Authors:  T Todo; R L Martuza; S D Rabkin; P A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

2.  Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms.

Authors:  Melanie E Dobbs; Jane E Strasser; Chin-Fun Chu; Claudia Chalk; Gregg N Milligan
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection.

Authors:  Richard B Pyles; Debbie Higgins; Claudia Chalk; Anthony Zalar; Joseph Eiden; Carrie Brown; Gary Van Nest; Lawrence R Stanberry
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Role of CD28/CD80-86 and CD40/CD154 costimulatory interactions in host defense to primary herpes simplex virus infection.

Authors:  K H Edelmann; C B Wilson
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

5.  Tumor necrosis factor (TNF) protects resistant C57BL/6 mice against herpes simplex virus-induced encephalitis independently of signaling via TNF receptor 1 or 2.

Authors:  Patric Lundberg; Paula V Welander; Carl K Edwards; Nico van Rooijen; Edouard Cantin
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

6.  CD4+ T cells are required for the priming of CD8+ T cells following infection with herpes simplex virus type 1.

Authors:  Naveen K Rajasagi; Sadik H Kassim; Christina M Kollias; Xiangyi Zhao; Robert Chervenak; Stephen R Jennings
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

7.  The antiviral efficacy of the murine alpha-1 interferon transgene against ocular herpes simplex virus type 1 requires the presence of CD4(+), alpha/beta T-cell receptor-positive T lymphocytes with the capacity to produce gamma interferon.

Authors:  Daniel J J Carr; Sansanee Noisakran
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  Dissection of antiviral and immune regulatory functions of tumor necrosis factor receptors in a chronic lymphocytic choriomeningitis virus infection.

Authors:  M Suresh; Xiaoyan Gao; Christopher Fischer; Nicole E Miller; Kavita Tewari
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

9.  Inhibition of MHC class I is a virulence factor in herpes simplex virus infection of mice.

Authors:  Mark T Orr; Kurt H Edelmann; Jeffrey Vieira; Lawrence Corey; David H Raulet; Christopher B Wilson
Journal:  PLoS Pathog       Date:  2005-09-30       Impact factor: 6.823

10.  Case Report: Rapid Recognition and Immune Modulation of Secondary HLH Due to Disseminated HSV Infection.

Authors:  Daniel J McKeone; Theodore K M DeMartini; Robert P Kavanagh; E Scott Halstead
Journal:  Front Pediatr       Date:  2021-07-02       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.